Clinical trials
Pleural Effusion trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Brigham and Women's Hospital | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| University of California, Davis | 2 |
| Albany Medical College | 1 |
| Amgen | 1 |
| CanBas Co. Ltd. | 1 |
| ClearFlow, Inc. | 1 |
| Colorado State University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pleural Effusion | 43 |
| Lung Neoplasms | 7 |
| Pleural Effusion, Malignant | 7 |
| Neoplasms | 5 |
| Pleural Diseases | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Pneumothorax | 4 |
| Heart Failure | 3 |
| Pulmonary Edema | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.